BioVie Inc. Net Income (Loss) Available to Common Stockholders, Basic
BioVie Inc. (BIVI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$33.01 million for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2024-09-30
- BioVie Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-06-30 was -$4.94M.
- BioVie Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-03-31 was -$8.95M.
- BioVie Inc. net income (loss) available to common stockholders, basic for the quarter ending 2023-12-31 was -$8.40M.
- BioVie Inc. net income (loss) available to common stockholders, basic for the quarter ending 2023-09-30 was -$10.71M.
- BioVie Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$33.01M.
- BioVie Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$50.26M.
- BioVie Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$26.08M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$13.90M derived: sum of 2 quarters · filed 2024-09-30 | -$22.30M derived: sum of 3 quarters · filed 2024-09-30 | -$33.01M 10-K · filed 2024-09-30 |
| 2024-03-31 | -$8.95M 10-Q · filed 2024-05-14 | -$17.36M derived: sum of 2 quarters · filed 2024-05-14 | -$28.07M 10-Q · filed 2024-05-14 | -$37.18M derived: sum of 4 quarters · filed 2024-09-30 |
| 2023-12-31 | -$8.40M 10-Q · filed 2024-02-13 | -$19.11M 10-Q · filed 2024-02-13 | -$28.22M derived: sum of 3 quarters · filed 2024-09-30 | -$43.27M derived: sum of 4 quarters · filed 2024-09-30 |
| 2023-09-30 | -$10.71M 10-Q · filed 2023-11-08 | -$19.82M derived: sum of 2 quarters · filed 2024-09-30 | -$34.86M derived: sum of 3 quarters · filed 2024-09-30 | -$50.55M derived: sum of 4 quarters · filed 2024-09-30 |
| 2023-06-30 | -$9.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$24.15M derived: sum of 2 quarters · filed 2024-09-30 | -$39.84M derived: sum of 3 quarters · filed 2024-09-30 | -$50.26M 10-K · filed 2024-09-30 |
| 2023-03-31 | -$15.04M 10-Q · filed 2024-05-14 | -$30.73M derived: sum of 2 quarters · filed 2024-05-14 | -$41.14M 10-Q · filed 2024-05-14 | -$49.23M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$15.69M 10-Q · filed 2024-02-13 | -$26.10M 10-Q · filed 2024-02-13 | -$34.19M derived: sum of 3 quarters · filed 2024-02-13 | -$41.23M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | -$10.42M 10-Q · filed 2023-11-08 | -$18.50M derived: sum of 2 quarters · filed 2023-11-08 | -$25.55M derived: sum of 3 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$8.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | -$15.13M derived: sum of 2 quarters · filed 2023-08-16 | -$26.08M 10-K · filed 2023-08-16 | |
| 2022-03-31 | -$7.04M 10-Q · filed 2023-05-12 | -$18.00M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |